Hexima Ltd., an Australian agricultural biotechnology company, rose by the most since first trading last year in Sydney after signing a corn seed development agreement with DuPont Co., the third-largest U.S. chemical maker. The Melbourne-based company will work with DuPont’s Pioneer unit to establish a commercial genetically modified corn product resistant to fungal diseases, Chairman Dan O’Brien said today in an interview at a commodities conference in Sydney.